Prognostic value of chromogranin-a (CGA) compared to circulating tumor cells (CTCs) in metastatic castration resistant prostate cancer (mCRPC).

被引:0
|
作者
Giridhar, Karthik
Sanhueza, Cristobal T.
Hillman, David W.
Alkhateeb, Hassan
Carlson, Rachel
Tan, Winston
Quevedo, Fernando
Pagliaro, Lance C.
Costello, Brian Addis
Kohli, Manish
机构
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA
[3] Mayo Clin, Jacksonville, FL 32224 USA
关键词
D O I
10.1200/JCO.2018.36.6_suppl.249
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
249
引用
收藏
页数:1
相关论文
共 50 条
  • [1] CD133 expression in circulating tumor cells (CTCs) from metastatic castration-resistant prostate cancer (mCRPC).
    Ana Marcos, Rosa
    Alfonso, Sara
    Lozano, Rebeca
    Matos, Ignacio
    Espinet, Blanca
    Garcia, Rocio
    Maria Hernandez, Jesus
    Gomez-Veiga, Francisco
    Luis Hernandez, Juan
    Cruz, Juan J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy
    Armstrong, Andrew J.
    Li, Jing
    Beaver, Joshua
    Bitting, Rhonda Lynn
    Gregory, Simon
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [3] Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy
    Li, Jing
    Beaver, Joshua
    Bitting, Rhonda Lynn
    Gregory, Simon
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Phenotypic, genomic, and clinical associations of Circulating Tumor Cells (CTCs) lacking epithelial biomarkers in metastatic Castration Resistant Prostate Cancer (mCRPC)
    Graf, Ryon P.
    Wang, Yipeng
    Schreiber, Nicole
    McLaughlin, Brigit
    Greene, Stephanie
    Rodriguez, Angel
    Jendrisak, Adam
    Lee, Jerry
    Landers, Mark
    Dittamore, Ryan
    Scher, Howard I.
    CANCER RESEARCH, 2017, 77
  • [5] Detection and Genomic Interrogation of Circulating Tumor Cells (CTCs) and Circulating Tumor Stem Cells (CTSCs) From Men with Metastatic Castration-resistant Prostate Cancer (mCRPC)
    Friedlander, T.
    Ngo, V.
    Doty, S.
    Zhao, Q.
    Dong, H.
    Ryan, C.
    Chen, W.
    Paris, P.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 152 - 152
  • [6] Detection and genomic interrogation of circulating tumor cells (CTCs) and circulating tumor stem cells (CTSCs) from men with metastatic castration-resistant prostate cancer (mCRPC)
    Friedlander, Terence W.
    Vy Ngo
    Doty, Shaun
    Zhao, Qiang
    Dong, Huang
    Ryan, Charles J.
    Chen, Wen-Tien
    Paris, Pamela
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [7] MOLECULAR PROFILING OF PERIPHERAL BLOOD IS ASSOCIATED WITH CIRCULATING TUMOR CELLS (CTCS) CONTENT AND SURVIVAL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)
    Gaba Garcia, L.
    Marin-Aguilera, M.
    Lozano, J. J.
    Tagliapietra, A.
    Ortega, V.
    Gascon, P.
    Mellado, B.
    ANNALS OF ONCOLOGY, 2012, 23 : 300 - 300
  • [8] Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy.
    Li, Jing
    Beaver, Joshua
    Bitting, Rhonda Lynn
    Gregory, Simon
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Simple and rapid enrichment of circulating tumor cells (CTCs) for RNAseq in metastatic castrate resistant prostate cancer (mCRPC).
    Morrison, Gareth
    Cunha, Alexander
    Jojo, Nita
    Manojlovic, Zarko
    Xu, Yucheng
    Robinson, Peggy S.
    Dorff, Tanya B.
    Quinn, David I.
    Goldkorn, Amir
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Detection of glucocorticoid receptor (GR) expression in circulating tumor cells (CTCs) from patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
    Wise, David
    Louw, Jessica
    Krupa, Rachel
    Schreiber, Nicole A.
    Sawyers, Charles L.
    Dittamore, Ryan Vance
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)